WHO ICTRP trial
Stimulation of the ovaries in women with breast cancer undergoing fertility…
NL-OMON47167 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON47167 |
|---|---|
| Public title | Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: alternative versus standard stimulation protocols; the STIM-trial |
| Scientific title | Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: alternative versus standard stimulation protocols; the STIM-trial - STIM-trial |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Belgium |
| Conditions | breast cancer mamma carcinoma;10006291;10018515;breast cancer;mamma carcinoma |
| Interventions | The first group of women will receive standard COS with tamoxifen 60 mg per day orally. The second group of women will receive standard COS with Letrozole 5 mg per day orally. The third group will receive standard COS ;breast… |
| Registration date | Mar 15, 2018 |
| Target size | 149 |
| Secondary IDs | 2013-000801-21;NL43808.018.13 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: